跳至主要内容
临床试验/EUCTR2011-002104-32-DE
EUCTR2011-002104-32-DE进行中(未招募)不适用

A trial investigating the pharmacokinetic properties of FIAsp in children, adolescents and adults with type 1 diabetes

ovo Nordisk A/S0 个研究点开始时间: 2013年10月10日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Male or female aged 6–64 years (both inclusive) at the time of signing informed consent.
  • 2. Type 1 diabetes mellitus (as diagnosed clinically) = 12 months.
  • 3. Body mass index (BMI) for children and adolescents (male and female) between the 3rd and 97th BMI percentile and for adults = 28.0 kg/m^2.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 26
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 13
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Subject who has donated any blood or plasma in the past month or more than 500 mL within 3 months prior to screening.
  • 2. Smoker (defined as a subject who is smoking at least one cigarette, cigar or pipe daily).
  • 3. Not able or willing to refrain from smoking and use of nicotine substitute products during the inpatient period.

研究者

相似试验